2m 2m 2m 2m 2m 2m 2m
4D MOLECULAR (FDMT)
NASDAQ
$11.79+$0.19 (+1.59%)
Price as of Jun 23, 2026 7:50 PM EDT- $544.7MMarket Cap
- 190.00%1-Year Change
- BiotechnologyIndustry
4D MOLECULAR (FDMT)
$11.79+$0.19 (+1.59%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 85.2M +230,194.59% | 37,000 -99.82% | 20.7M +562.29% | 3.1M -82.65% | |
Cost of Revenue | N/A N/A | N/A N/A | 0 N/A | N/A N/A | |
Gross Profit | 85.2M +230,194.59% | 37,000 -99.82% | 20.7M +562.29% | 3.1M -82.65% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -195.7M +38.50% | -141.3M +45.53% | -97.1M +20.99% | -80.3M +30.79% | |
Depreciation and Amortization Expense | 4.7M +0.88% | 4.7M +10.68% | 4.2M +74.95% | 2.4M +57.78% | |
Total Operating Expenses | 244.8M +30.27% | 187.9M +40.64% | 133.6M +18.05% | 113.2M +26.62% | |
Operating Profit | -159.5M -15.06% | -187.8M +66.43% | -112.9M +2.58% | -110.0M +54.25% | |
Interest Income | 19.5M -28.00% | 27.1M +121.52% | 12.2M +374.58% | 2.6M +1,778.10% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 19.5M -28.00% | 27.1M +121.52% | 12.2M +374.58% | 2.6M +1,778.10% | |
Total Nonoperating Income and Expense | 19.4M -27.94% | 27.0M +124.21% | 12.0M +374.00% | 2.5M +15,762.50% | |
Income before Taxes | -159.5M -15.06% | -187.8M +66.43% | -112.9M +2.58% | -110.0M +54.25% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -140.1M -12.90% | -160.9M +59.53% | -100.8M -6.19% | -107.5M +50.73% | |
Net Income from Continuing Operations Applicable to Common | -140.1M -12.90% | -160.9M +59.53% | -100.8M -6.19% | -107.5M +50.73% | |
Basic EPS and Net Income | -2.42 -18.79% | -2.98 +15.50% | -2.58 -22.29% | -3.32 +29.18% | |
Diluted EPS and Net Income | -2.42 -18.79% | -2.98 +15.50% | -2.58 -22.29% | -3.32 +29.18% | |
Basic Weighted Average Shares | 57.9M +7.39% | 53.9M +37.86% | 39.1M +20.95% | 32.4M +16.66% | |
Diluted Weighted Average Shares | 57.9M +7.39% | 53.9M +37.86% | 39.1M +20.95% | 32.4M +16.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 60.2M -59.66% | 149.3M -40.05% | 249.1M +375.84% | 52.4M -65.78% | |
Short-Term Investments | 342.4M +24.27% | 275.5M +604.28% | 39.1M -75.73% | 161.2M +70.09% | |
Cash and Cash Equivalents and Short-Term Investments | 402.7M -5.23% | 424.9M +47.41% | 288.2M +34.97% | 213.6M -13.81% | |
Total Current Assets | 413.1M -5.01% | 434.9M +46.65% | 296.6M +34.50% | 220.5M -13.96% | |
Accumulated Depreciation | 21.3M +28.30% | 16.6M +39.00% | 11.9M +54.40% | 7.7M +45.13% | |
Property and Plant and Equipment and Net | 14.9M -23.89% | 19.5M -2.94% | 20.1M -9.59% | 22.3M +54.69% | |
Total Long-Term Assets | 9.2M +115.63% | 4.3M +522.95% | 684,000 -36.67% | 1.1M +79.40% | |
Total Assets | 566.7M +1.13% | 560.4M +64.87% | 339.9M +29.81% | 261.8M -25.92% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 44.0M +50.90% | 29.1M +53.81% | 19.0M +20.47% | 15.7M -3.72% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 138,000 -28.50% | 193,000 -22.18% | 248,000 +1,080.95% | 21,000 -82.50% | |
Total Liabilities | 61.0M +22.64% | 49.8M +55.26% | 32.1M +5.09% | 30.5M -11.26% | |
Retained Earnings | -716.3M +24.32% | -576.2M +38.73% | -415.3M +32.06% | -314.5M +51.93% | |
Total Stockholders Equity | 505.7M -0.97% | 510.6M +65.87% | 307.8M +33.07% | 231.3M -27.50% | |
Total Shares Outstanding | 57.6M +25.80% | 45.8M +6.31% | 43.1M +32.02% | 32.6M +1.25% | |
Cash Flow | |||||
Cash from Operating Activities | -109.1M -18.95% | -134.6M +77.57% | -75.8M -12.57% | -86.7M +25.39% | |
Capital Expenditures | 536,000 -85.84% | 3.8M +36.63% | 2.8M -75.98% | 11.5M +26.63% | |
Cash from Investing Activities | -93.0M -69.26% | -302.4M -361.36% | 115.7M +778.69% | -17.1M -90.13% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 113.0M -66.51% | 337.3M +115.04% | 156.8M +4,983.70% | 3.1M -97.39% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 100.00% N/A | N/A N/A | |
Operating Margin | -187.24% -99.96% | -507,678.38% +93,112.54% | -544.65% -84.51% | -3,516.52% +789.22% | |
Return on Assets | -24.86% -30.43% | -35.74% +6.63% | -33.52% -4.07% | -34.94% +57.21% | |
Return on Equity | -27.57% -29.86% | -39.31% +5.10% | -37.40% -4.23% | -39.06% +57.59% | |
Revenue Growth | 230,194.59% +230,706.23% | -99.82% -117.75% | 562.29% +780.30% | -82.65% -354.20% | |
Current Ratio | 9.39 -37.05% | 14.92 -4.66% | 15.65 +11.65% | 14.02 -10.64% | |
Cash Ratio | 1.37 -73.27% | 5.12 -61.02% | 13.14 +294.99% | 3.33 -64.46% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow